Compugen Ltd. (CGEN) was a big mover last session, as its shares rose nearly 6% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend for the company since Oct 28, as the stock is now down almost 13%.
Over the last 30 days, this biopharmaceutical company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Compugen currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Other well-performing biomedical stocks include AMAG Pharmaceuticals, Inc. (AMAG), ANI Pharmaceuticals, Inc. (ANIP) and Biogen Idec Inc. (BIIB). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment